Alyeska Investment Group L.P. cut its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 98.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,349 shares of the company’s stock after selling 1,213,691 shares during the quarter. Alyeska Investment Group L.P.’s holdings in Acadia Healthcare were worth $529,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ACHC. Tidal Investments LLC grew its stake in Acadia Healthcare by 7.9% in the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock valued at $296,000 after buying an additional 340 shares in the last quarter. Franklin Resources Inc. grew its position in shares of Acadia Healthcare by 273.1% in the third quarter. Franklin Resources Inc. now owns 105,228 shares of the company’s stock valued at $6,673,000 after purchasing an additional 77,027 shares in the last quarter. Principal Financial Group Inc. raised its stake in shares of Acadia Healthcare by 2.1% during the 3rd quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock valued at $41,653,000 after purchasing an additional 13,368 shares during the period. JPMorgan Chase & Co. lifted its holdings in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares in the last quarter. Finally, GAMMA Investing LLC boosted its stake in Acadia Healthcare by 259.6% in the 4th quarter. GAMMA Investing LLC now owns 2,384 shares of the company’s stock worth $95,000 after purchasing an additional 1,721 shares during the period.
Acadia Healthcare Trading Up 4.3 %
ACHC stock opened at $23.80 on Wednesday. The company has a market capitalization of $2.19 billion, a PE ratio of 7.80, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a one year low of $20.36 and a one year high of $82.41. The company’s 50 day moving average price is $26.92 and its two-hundred day moving average price is $37.00.
Analysts Set New Price Targets
Get Our Latest Report on Acadia Healthcare
Acadia Healthcare Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 Mid-Cap Medical Stocks Outperforming the Market
- How is Compound Interest Calculated?
- The Top-Ranked Insider Buys From April by Market Cap
- How to Invest in Blue Chip Stocks
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.